Status and phase
Conditions
Treatments
About
The primary objective of this study is to compare the effectiveness of standard medical therapy alone to kyphoplasty using the KyphX system for the treatment of acute vertebral body compression fractures.
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Previous vertebroplasty;
Vertebral body fracture morphology prevents use of devices (such as endplate below pedicles);
Pedicle fractures;
Acute fracture(s) to be treated symptomatic > 3 months at enrollment;
Pre-existing (not the result of the index fracture) neurological deficit or radicular pain that is not well defined or unstable;
Spinal cord compression or canal compromise requiring decompression;
Disabling back pain secondary to causes other than acute fracture;
Vertebral fracture due to primary or osteoblastic tumors;
Patient is currently on anticoagulation therapy that can not be interrupted;
Pre-existing conditions contrary to the kyphoplasty procedure:
Known allergy to any of the drugs, bone void filler material or contrast medium used in the treatment of study subjects
Dementia and/or inability to give informed consent;
Inability to walk or stand prior to the vertebral body fracture (walking aids are allowed);
MRI contraindication (e.g. cerebral aneurysm clips, pacemaker, implanted biostimulators, cochlear implants, penile prosthesis);
Pregnancy
Participation in any other clinical trial within the last 30 days.
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal